6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine

Catalog No. :
ACHNTP758
CAS No. :
75510-02-0
Molecular Formula :
C15H16N2
Molecular Weight :
224.31

IUPAC Name:6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine

6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$318.00Login to see priceInquiryInquiry
1g95%$637.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine
IUPAC Name6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine
MDL No.MFCD01938287
Molecular FormulaC15H16N2
Molecular Weight224.31
SMILESC12=C(N=CC=C2)CCN(CC3=CC=CC=C3)C1
InChI KeyOGXKXWUYFHASPY-UHFFFAOYSA-N
Synonym6-benzyl-7,8-dihydro-5H-1,6-naphthyridine;6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine;6-benzyl-5,6,7,8-tetrahydro-1,6-naph6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridinethyridine;1,6-Naphthyridine, 5,6,7,8-tetrahydro-6-(phenylmethyl)-
CAS No.75510-02-0
PubChem CID3058713

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHNTP758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEYXK324 route compound structure diagram
    ACEYXK3241187830-51-8 In Stock
  4. Then
  5. ACHNTP758 route product structure diagram
    ACHNTP75875510-02-0
Inquiry

2. ACHNTP758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEYXK324 route compound structure diagram
    ACEYXK3241187830-51-8 In Stock
  4. Then
  5. ACHNTP758 route product structure diagram
    ACHNTP75875510-02-0
Inquiry

Comments (0)